Podcast episode 137 (in German)

GlyNAC – two cheap building blocks, a patent and the question of the sum

November 14, 2026

Glycine and NAC are supposed to give cells back the material for glutathione, and in Houston it rose in old muscles almost to the level of the young. Then, of all people, the licensee measures again — and the two findings contradict each other less than it seems.

What it is about

GlyNAC is the combination of glycine, the smallest amino acid, and N-acetylcysteine, a precursor of cysteine. The idea is elegant: glutathione, the cell’s most important protective molecule, is built from building blocks, and in old age it is apparently the material that is missing, not the machinery. Almost all human data come from the lab of Rajagopal Sekhar at Baylor College of Medicine in Houston; the university holds a patent, licensed to Nestlé Health Science. There, with biopsy and placebo, it has been shown that glutathione in muscle can be replenished; gait, strength and lifespan are less well supported. The only study from outside found nothing, though with less than half the amount. The conclusion: it works in the studies as long as you take it; nobody has tested it over years.

Key points

In 2011, 8 older people had only about half as much glutathione as 8 younger people; after 2 weeks with both building blocks it was around 95 percent higher, without a control group.
In the 2023 randomized trial with 24 older people aged 61 to 80, muscle glutathione rose from 2.4 to 6.3 in 16 weeks, while in young people it is 7; under placebo it stayed at 2.4.
Markers of oxidative stress were 72 percent lower afterwards; gait and grip strength improved within the group, but the tables contain no direct comparison with placebo.
In the open-label pilot study with 8 older people, gait speed rose from 1 to 1.5 meters per second in 24 weeks and stood at 1.2 at 12 weeks after stopping.
16 mice given GlyNAC from middle age lived 128 instead of 104 weeks, an increase of 24 percent; the experiment cannot separate whether the supplement extended life or the 16 control animals died early.
The Nestlé Health Science study with 114 healthy older people over 2 weeks missed its primary endpoint; nobody dropped out there because of side effects.
In a patient survey of 3,925 people with chronic fatigue syndrome or long COVID, NAC scored clearly better than vitamin C, with a net score of around 46 points.

Where the data stop

Everything beyond the replenished glutathione — strength, gait, lifespan — comes from one lab holding a patent, from groups of 8 to 12 people, and disappears after stopping. Good methodology from one source remains one source until someone else replicates it. The Nestlé study is nevertheless not a clean counterproof: shorter, in younger people, measured in blood instead of muscle. No side effects stood out, but that is a few dozen people over 24 weeks at most. NAC accelerated tumor growth in mice with induced lung cancer, and in 2025 the cardiac benefit appeared only in male mice.

There is no evaluated collection of user reports on GlyNAC itself. The survey has no placebo, and only those with a clear opinion were supposed to respond; it does, however, fit the pattern that people who lack glutathione are more likely to notice something. In Germany NAC is a pharmacy medicine, and anyone who smokes or has a history of cancer checks this with a doctor beforehand.

Listen (in German)

Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music

Published on November 14, 2026.

The topic in the database

The longevity combination of glycine and NAC: supplies the building blocks for glutathione – in a small study by a single research group with improvements…GlyNAC (Glycine + NAC)

All episodes in the app (German)

Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-09-23.